When it comes to rewiring the biopharma operating model—simplification is key.🔑 To compete in an increasingly complex market, companies will need to unleash distinctive capabilities, reduce low-value work, speed up decision-making, and harness AI and digital. We break it down here: https://mck.co/41MMVQO
💡 Great insight
Evolving the biopharma operating model with tools that both speed up decision-making & enhance patient outcomes will be a game-changer. Great insights!
Thanks for sharing
Insightful
Great insights on the future of biopharma! Simplifying operations while embracing AI and digital transformation is a crucial step towards success.
Simplification truly is the cornerstone of a robust biopharma strategy. Emphasising distinctive capabilities and leveraging AI can drive significant results in this complex industry in my opinion. Great insights. Thank you for sharing...
Thanks for sharing 👍
Simplification isn’t just about cutting complexity—it’s about creating clarity, speed, and impact.
VP | AI & Digital Transformation Executive | Driving Strategy, People, Process & Technology for Measurable & Scalable Growth | GenAI, Data, ERP | M&A, Global P&L | Strategic Advisor, Speaker, Author | Forbes Tech Council
2dThis model speaks to what we’ve been trying to shape in healthcare for years. If I had to frame it, it’s: 1. Strip out legacy complexity 2. Re-center on high-value capabilities 3. Layer AI and digital where decisions move fastest Simple doesn’t mean easy—but this is the scaffolding that holds.